Exploring Multimorbidity in Patients With Spinal Pain
Launched by JACOB CHRISTIANSEN GANDLØSE · May 3, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "Exploring Multimorbidity in Patients With Spinal Pain," is investigating how having multiple chronic health conditions—like back or neck pain—affects patients. Many people with spinal pain also deal with other health issues, and this study aims to understand how these conditions interact and impact patients’ treatment and overall health. The research will be conducted at two hospitals in Denmark, focusing on adults aged 18 and older who have been diagnosed with neck or back pain by a rheumatologist.
Participants in this study can expect to share their health experiences and may help researchers learn more about how doctors can better treat patients with spinal pain who also have other health concerns. To be eligible, individuals must be at least 18 years old, have a confirmed diagnosis of neck or back pain, and be able to communicate in Danish. It's important to note that participants will be actively helping to uncover valuable insights that could improve care for others facing similar challenges.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 18 years old or above
- • Are diagnosed with neck or back pain
- • Diagnosis is established by or confirmed by a rheumatologist (clinical expert opinion)
- • Speak, read and understand Danish
- Exclusion Criteria:
- • Withdraw consent
About Jacob Christiansen Gandløse
Jacob Christiansen Gandløse is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes. With a focus on innovative therapies and rigorous scientific methodologies, the organization collaborates with a network of healthcare professionals and research institutions to conduct high-quality clinical trials. Their expertise spans multiple therapeutic areas, ensuring a comprehensive approach to testing and development. Jacob Christiansen Gandløse prioritizes ethical standards and patient safety, striving to contribute valuable insights to the medical community and enhance treatment options for patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Aalborg, Region Nordjylland, Denmark
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported